Skip to main content
School of Medicine
Precision Health Initiative
Traumatic Brain Injury
Graduate Medical Education
Health Professions Programs
Continuing Medical Education
Mental Health Services
Centers and Institutes
Northwest - Gary
Anatomy, Cell Biology and Physiology
Biochemistry Molecular Biology
Biostatistics and Health Data Science
Microbiology and Immunology
Pharmacology and Toxicology
Medical and Molecular Genetics
Obstetrics and Gynecology
Physical Medicine and Rehabilitation
Radiology and Imaging Sciences
Toggle Search Box
Attaya Suvannasankha, MD
Attaya Suvannasankha, MD
Associate Professor of Clinical Medicine
Joseph E. Walther Hall, Room C400
980 W. Walnut St.
Indianapolis , IN 46202
Titles & Appointments
Associate Professor of Clinical Medicine
Roswell Park Cancer Institute and State University, Buffalo, NY
Albert Einstein Medical Center, Philadelphia, PA
Molecular mechanism of drug resistance in hematologic malignancy
Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study.
Lonial S; Lee HC; Badros A; Trudel S; Nooka AK; Chari A; Abdallah AO; Callander N; Lendvai N; Sborov D; Suvannasankha A; Weisel K; Karlin L; Libby E; Arnulf B; Facon T; Hulin C; Kortüm KM; Rodríguez-Otero P; Usmani SZ; Hari P; Baz R; Quach H; Moreau P; Voorhees PM; Gupta I; Hoos A; Zhi E; Baron J; Piontek T; Lewis E; Jewell RC; Dettman EJ; Popat R; Esposti SD; Opalinska J; Richardson P; Cohen AD; The Lancet. Oncology 2019 Dec 16
Testicular plasmacytoma misdiagnosed as orchitis.
Schiavo C; Mann SA; Mer J; Suvannasankha A; 2018 Jun 4
The Role of Semaphorin 4D in Bone Remodeling and Cancer Metastasis.
Lontos K; Adamik J; Tsagianni A; Galson DL; Chirgwin JM; Suvannasankha A; 2018 Jun 19
Cold agglutinin-mediated autoimmune haemolytic anaemia associated with diffuse large B cell lymphoma.
Wongsaengsak S; Czader M; Suvannasankha A; 2018 Jul 10
Multiple 'doughnut' granulomas in a liver transplant patient with CMV reactivation.
Dejhansathit S; Miller AM; Suvannasankha A; 2018 Dec 22
Acute lymphoblastic leukaemia with osteolytic bone lesions: diagnostic dilemma.
Angsubhakorn N; Suvannasankha A; 2018 Aug 11
Multifocal myeloid sarcomas: a rare presentation of AML.
Angsubhakorn N; Suvannasankha A; BMJ case reports 2017 Oct 4
Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma.
Chari A; Suvannasankha A; Fay JW; Arnulf B; Kaufman JL; Ifthikharuddin JJ; Weiss BM; Krishnan A; Lentzsch S; Comenzo R; Wang J; Nottage K; Chiu C; Khokhar NZ; Ahmadi T; Lonial S; Blood 2017 Jun 21
Consecutive epigenetically-active agent combinations act in <i>ID1-RUNX3-TET2</i> and <i>HOXA</i> pathways for <i>Flt3ITD+ve</i> AML.
Sayar H; Liu Y; Gao R; Zaid MA; Cripe LD; Weisenbach J; Sargent KJ; Nassiri M; Li L; Konig H; Suvannasankha A; Pan F; Shanmugam R; Goswami C; Kapur R; Xu M; Boswell HS; Oncotarget 2017 Dec 25
Targeted nuclear factor-kappaB suppression enhances gemcitabine response in human pancreatic tumor cell line murine xenografts.
Waters JA; Matos J; Yip-Schneider M; Aguilar-Saavedra JR; Crean CD; Beane JD; Dumas RP; Suvannasankha A; Schmidt CM; Surgery 2015 Jul 21
FGF23 is elevated in multiple myeloma and increases heparanase expression by tumor cells.
Suvannasankha A; Tompkins DR; Edwards DF; Petyaykina KV; Crean CD; Fournier PG; Parker JM; Sandusky GE; Ichikawa S; Imel EA; Chirgwin JM; Oncotarget 2015 Aug 14
Regulation of ubiquitin-proteasome system-mediated Tip110 protein degradation by USP15.
Timani KA; Liu Y; Suvannasankha A; He JJ; The international journal of biochemistry & cell biology 2014 Jun 28
Tumor-expressed adrenomedullin accelerates breast cancer bone metastasis.
Siclari VA; Mohammad KS; Tompkins DR; Davis H; McKenna CR; Peng X; Wessner LL; Niewolna M; Guise TA; Suvannasankha A; Chirgwin JM; Breast cancer research : BCR 2014 Dec 2
Role of bone-anabolic agents in the treatment of breast cancer bone metastases.
Suvannasankha A; Chirgwin JM; Breast cancer research : BCR 2014
Temozolomide-mediated DNA methylation in human myeloid precursor cells: differential involvement of intrinsic and extrinsic apoptotic pathways.
Wang H; Cai S; Ernstberger A; Bailey BJ; Wang MZ; Cai W; Goebel WS; Czader MB; Crean C; Suvannasankha A; Shokolenkoc I; Wilson GL; Baluyut AR; Mayo LD; Pollok KE; Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Mar 27
Comparison of an assumption-free Bayesian approach with Optimal Sampling Schedule to a maximum a posteriori Approach for Personalizing Cyclophosphamide Dosing.
Laínez JM; Orcun S; Pekny JF; Reklaitis GV; Suvannasankha A; Fausel C; Anaissie EJ; Blau GE; Pharmacotherapy 2013 Aug 27
Validation of a novel approach for dose individualization in pharmacotherapy using gabapentin in a proof of principles study.
Blau GE; Orcun S; Laínez JM; Reklaitis GV; Suvannasankha A; Fausel C; Anaissie EJ; Pharmacotherapy 2013 Apr 3
A noncanonical Flt3ITD/NF-?B signaling pathway represses DAPK1 in acute myeloid leukemia.
Shanmugam R; Gade P; Wilson-Weekes A; Sayar H; Suvannasankha A; Goswami C; Li L; Gupta S; Cardoso AA; Al Baghdadi T; Sargent KJ; Cripe LD; Kalvakolanu DV; Boswell HS; Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Nov 17
Bortezomib (Velcade) treatment of AL amyloidosis: Indiana University experience.
Abonour R; Kramer G; Suvannasankha A; Benson MD; Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2011 Jun
Preclinical activity of a novel multiple tyrosine kinase and aurora kinase inhibitor, ENMD-2076, against multiple myeloma.
Wang X; Sinn AL; Pollok K; Sandusky G; Zhang S; Chen L; Liang J; Crean CD; Suvannasankha A; Abonour R; Sidor C; Bray MR; Farag SS; British journal of haematology 2010 Jun 15
The novel histone deacetylase inhibitor, AR-42, inhibits gp130/Stat3 pathway and induces apoptosis and cell cycle arrest in multiple myeloma cells.
Zhang S; Suvannasankha A; Crean CD; White VL; Chen CS; Farag SS; International journal of cancer. Journal international du cancer 2010 Dec 1
Gastrointestinal plasmacytoma presenting as gastrointestinal bleeding.
Suvannasankha A; Abonour R; Cummings OW; Liangpunsakul S; Clinical lymphoma & myeloma 2008 Oct
Antimyeloma effects of a sesquiterpene lactone parthenolide.
Suvannasankha A; Crean CD; Shanmugam R; Farag SS; Abonour R; Boswell HS; Nakshatri H; Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Mar 15
Deep vein thrombosis and pulmonary embolism in cirrhosis patients.
Gulley D; Teal E; Suvannasankha A; Chalasani N; Liangpunsakul S; Digestive diseases and sciences 2008 Apr 29
Final report of toxicity and efficacy of a phase II study of oral cyclophosphamide, thalidomide, and prednisone for patients with relapsed or refractory multiple myeloma: A Hoosier Oncology Group Trial, HEM01-21.
Suvannasankha A; Fausel C; Juliar BE; Yiannoutsos CT; Fisher WB; Ansari RH; Wood LL; Smith GG; Cripe LD; Abonour R; The oncologist 2007 Jan
OSU-03012, a novel celecoxib derivative, is cytotoxic to myeloma cells and acts through multiple mechanisms.
Zhang S; Suvannasankha A; Crean CD; White VL; Johnson A; Chen CS; Farag SS; Clinical cancer research : an official journal of the American Association for Cancer Research 2007 Aug 15
Weekly bortezomib/methylprednisolone is effective and well tolerated in relapsed multiple myeloma.
Suvannasankha A; Smith GG; Juliar BE; Abonour R; Clinical lymphoma & myeloma 2006 Sep
Hematologic malignancies; multiple myeloma
Looking for patient care?
To schedule an appointment with a faculty member physician of IU School of Medicine, contact Indiana University Health at 888-484-3258 or use the physician finder by clicking the button below.
Find a doctor